Eduardo Arellano-Rodrigo1, Mercedes Gironella, Inmaculada Nicolau, Miquel Vila. Show Affiliations » 1. Department of Haemostasis and Thrombosis, Hospital General Vall d'Hebron, Pg. Vall d'Hebron, 119-129, Barcelona 08035, Spain. 34004ear@comb.cat
Abstract
Entities: Disease
Mesh: See more » Acenocoumarol/adverse effectsAcenocoumarol/therapeutic useAgedAged, 80 and overAnticoagulants/adverse effectsAnticoagulants/therapeutic useDrug MonitoringEnoxaparin/adverse effectsEnoxaparin/therapeutic useFactor VII Deficiency/bloodFactor VII Deficiency/complicationsFactor VII Deficiency/drug therapyHemorrhage/chemically inducedHumansInternational Normalized RatioMaleRisk AssessmentThrombosis/bloodThrombosis/drug therapyThrombosis/etiologyTime FactorsTreatment Outcome
Substances: See more » AnticoagulantsEnoxaparinAcenocoumarol
Year: 2009 PMID: 19190828
Source DB: PubMed Journal: Thromb Haemost ISSN: 0340-6245 Impact factor: 5.249